SPLITOAK STRATEGIES LLC

Lobbying for CARIS SCIENCE INC · Providing precision medicine services to patients battling aggressive cancers.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Texas · House · Senate · $40,000.00 income · posted Jul 21, 2025

Lobbying activity 2

Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare

Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools; Appropriate standards in oversight of lab-developed tests

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.